Patents by Inventor Elisabet LÁZARO MALLÉN

Elisabet LÁZARO MALLÉN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11478423
    Abstract: A self-film-forming composition in powder form, a reconstituted formula and a kit for oral use are provided, which allow an adequate colonization of the probiotic in the oral cavities together with a sufficient residence time to allow beneficial effects against the pathogens related with oral conditions. Thus, the items provided are useful for the prevention and/or treatment of a condition related to alterations of the oral microbiota, and specifically for peri-implantitis. The self-film-forming composition in powder form comprises at least a gelifier agent and/or at least a bioadhesive agent, and at least one lactic acid bacteria strain.
    Type: Grant
    Filed: July 11, 2016
    Date of Patent: October 25, 2022
    Assignee: AB-BIOTICS, S.A.
    Inventors: Jonatan Santas Gutiérrez, Elisabet Lázaro Mallén, Jordi Cuné Castellana, Javier Mareque Mareque Bueno, Jose Luis Calvo Guirado
  • Patent number: 10265351
    Abstract: Provided is a bacterial composition which comprises from 104 to 1012 cfu/g of Pediococcus pentosaceus cells which have the ability to induce the production of interleukin-10 to reduce inflammation in the intestinal tract among other features and is useful in the amelioration of excessive crying in infants.
    Type: Grant
    Filed: August 7, 2014
    Date of Patent: April 23, 2019
    Assignees: AB-BIOTICS, S.A., VANPHARMA LABORATORIOS, S. A.
    Inventors: Jordi Cune Castellana, Elisabet Lazaro Mallen, Jordi Espadaler Mazo
  • Publication number: 20190000757
    Abstract: A self-film-forming composition in powder form, a reconstituted formula and a kit for oral use are provided, which allow an adequate colonization of the probiotic in the oral cavities together with a sufficient residence time to allow beneficial effects against the pathogens related with oral conditions. Thus, the items provided are useful for the prevention and/or treatment of a condition related to alterations of the oral microbiota, and specifically for peri-implantitis. The self-film-forming composition in powder form comprises at least a gelifier agent and/or at least a bioadhesive agent, and at least one lactic acid bacteria strain.
    Type: Application
    Filed: July 11, 2016
    Publication date: January 3, 2019
    Inventors: Jonatan SANTAS GUTIÉRREZ, Elisabet LÁZARO MALLÉN, Jordi CUNÉ CASTELLANA, Javier, Mareque MAREQUE BUENO, Jose, Luis CALVO GUIRADO
  • Publication number: 20180008652
    Abstract: The invention provides a bacterial composition which comprises from 104 to 1012 cfu/g of Pediococcus pentosaceus cells which have the ability to induce the production of interleukin-10 to reduce inflammation in the intestinal tract among other features. Thus, the bacterial composition is useful in the amelioration of excessive crying in infants. Particularly, Pediococcus pentosaceus cells are from the strain deposited as CECT 8330. The bacterial composition can be in the form of a food supplement, a medicament, an infant formula, an edible product and a food product. Particularly, the composition is in the form of an infant food supplement in the form of oily suspension.
    Type: Application
    Filed: July 18, 2017
    Publication date: January 11, 2018
    Applicants: AB-BIOTICS, S.A., VENPHARMA LABORATORIOS, S. A.
    Inventors: Jordi CUNE CASTELLANA, Elisabet LAZARO MALLEN, Jordi ESPADALER MAZO
  • Publication number: 20160184371
    Abstract: Provided is a bacterial composition which comprises from 104 to 1012 cfu/g of Pediococcus pentosaceus cells which have the ability to induce the production of interleukin-10 to reduce inflammation in the intestinal tract among other features and is useful in the amelioration of excessive crying in infants
    Type: Application
    Filed: August 7, 2014
    Publication date: June 30, 2016
    Applicants: AB-BIOTICS, S.A., VENPHARMA LABORATORIOS, S. A.
    Inventors: Jordi CUNE CASTELLANA, Elisabet LAZARO MALLEN, Jordi ESPADALER MAZO